Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

Clinical trial NCT00637195 · COMPLETED

Trial details

NCT number: NCT00637195
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Papillomavirus Papillomavirus Vaccines

Start date: 2008-03-11
Primary completion: 2008-06-20
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.